Causes of Hemoptysis in Renal Transplant Patients

dc.contributor.authorSerifoglu, Irem
dc.contributor.authorDedekarginoglu, Balam Er
dc.contributor.authorSoy, Ebru Hatice Ayvazoglu
dc.contributor.authorUlubay, Gaye
dc.contributor.authorHaberal, Mehmet
dc.contributor.orcID0000-0002-0993-9917en_US
dc.contributor.orcID0000-0003-2478-9985en_US
dc.contributor.orcID0000-0002-3462-7632en_US
dc.contributor.pubmedID29527996en_US
dc.contributor.researcherIDAAS-6628-2021en_US
dc.contributor.researcherIDAAC-5566-2019en_US
dc.contributor.researcherIDAAJ-8097-2021en_US
dc.date.accessioned2023-04-27T12:52:51Z
dc.date.available2023-04-27T12:52:51Z
dc.date.issued2018
dc.description.abstractObjectives: Hemoptysis is a symptom that can be caused by airway disease, pulmonary parenchymal disease, or pulmonary vascular disease, or it can be idiopathic. Infection is the most common cause of hemoptysis, accounting for 60% to 70% of cases. Hemoptysis is also an initial symptom of diffuse alveolar hemorrhage syndrome, although it may be absent at presentation in one-third of patients. Diffuse alveolar hemorrhage is characterized by disruption of the alveolar-capillary basement membranes because of either injury or inflammation of the arterioles, venules, or capillaries, resulting in bleeding in alveolar spaces. To date, no study in the literature has investigated the cause of hemoptysis in renal transplant patients. In this retrospective study, we aimed to investigate the causes of hemoptysis in renal recipients. Materials and Methods: The data included in this study were obtained from 352 renal transplant patients who were consulted by the pulmonology department regarding hemoptysis between 2011 and 2017 at Baskent University. Patient medical records were reviewed for demographic, clinical, radiographic, bronchoscopic features, and microbiology data. Immunosuppressive drugs and clinical outcome data were also noted. Results: This study included 352 renal transplant patients (139 male patients with mean age of 34.9 +/- 7 years and 113 female patients with mean age of 31.1 +/- 5 years). Hemoptysis was detected in 17 patients (4.8%),with 3 (0.85%) having massive hemoptysis as a result of diffuse alveolar hemorrhage syndrome. Fourteen of our patient group (4%) had pneumonia, and Aspergillus species was detected in 5 patients (1.4%). The only reason for diffuse alveolar hemorrhage was immunosuppressive agents, including sirolimus and mycophenolate mofetil. Conclusions: Hemoptysis is an important respiratory symptom in renal transplant patients. Although community- or hospital-acquired pneumonia may result in hemoptysis, drug-induced diffuse alveolar hemorrhage and Aspergillus infection should be considered for causes in renal transplant patients.en_US
dc.identifier.endpage74en_US
dc.identifier.issn1304-0855en_US
dc.identifier.issueSupplement 1en_US
dc.identifier.scopus2-s2.0-85044153327en_US
dc.identifier.startpage70en_US
dc.identifier.urihttp://hdl.handle.net/11727/8878
dc.identifier.volume16en_US
dc.identifier.wos000454174600016en_US
dc.language.isoengen_US
dc.relation.isversionof10.6002/ect.TOND-TDTD2017.O30en_US
dc.relation.journalEXPERIMENTAL AND CLINICAL TRANSPLANTATIONen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDiagnosisen_US
dc.subjectHemoptysisen_US
dc.subjectTransplantationen_US
dc.titleCauses of Hemoptysis in Renal Transplant Patientsen_US
dc.typearticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: